SEC Form 4 · accession 0001055726-19-000014

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Peter Kies

Officer — CFO

Period of report

Mar 8, 2019

Accepted (ET)

Mar 12, 2019 · 5:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001055726

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Mar 9, 2019	M	25,000	—	A	104,354	D
Common Stock	Mar 9, 2019	F	8,591	$3.34	D	95,763	D
Common Stock^F3	Mar 10, 2019	M	20,433	—	A	116,196	D
Common Stock	Mar 10, 2019	F	7,066	$3.34	D	109,130	D
Common Stock	holding	—	—		—	4,500	I	By Spouse

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F1	—	Mar 9, 2019	M	25,000	D	—	—	Common Stock	25,000	0	D
Restricted Stock Unit^F3	—	Mar 10, 2019	M	20,433	D	—	—	Common Stock	20,433	20,433	D
Common Stock Option^F5	$3.34	Mar 8, 2019	A	100,500	A	Mar 8, 2019	Mar 8, 2029	Common Stock	100,500	100,500	D
Restricted Stock Unit^F6	—	Mar 8, 2019	A	64,400	A	—	—	Common Stock	64,400	64,400	D

Explanation of responses

F1Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 75,000 restricted stock units was as follows: 25,000 shares vested on March 9, 2017; 25,000 shares vested on March 9, 2018; 25,000 shares vested on March 9, 2019.
F2The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units award reported in footnote (1) herein.
F3Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 61,300 restricted stock units is as follows: 20,434 shares vested on March 10, 2018; 20,433 shares vested on March 10, 2019; 20,433 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock units award reported in footnote (3) herein.
F5The vesting schedule for the 100,500 options is as follows: 25,125 shares vested on March 8, 2019; 25,125 shares will vest on March 8, 2020; 25,125 shares will vest on March 8, 2021; 25,125 shares will vest on March 8, 2022.
F6Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 64,400 restricted stock units is as follows: 21,467 shares will vest on March 8, 2020; 21,467 shares will vest on March 8, 2021; 21,466 shares will vest on March 8, 2022.Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.